ArticleScientific reports2026
Sequential biosorptive-degradative remediation of methylene blue from polluted soil and wastewater by a newly isolated Bacillus safensis SMAH biomass: optimization, kinetics, isotherms and thermodynamics assessments.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rising necessity for available environmentally sustainable and low-cost effective soil remediation technology has driven our efforts to conduct this research investigation. A laboratory-based experimental approach has been designed and applied to assess the effective action of a new bacterial biomass for the biosorption-biodegradation of methylene blue dye (Mbd) from contaminated soil and wastewater. A dried biosorbent of Bacillus safensis strain SMAH biomass (BS-SMAH-B), was isolated from tannery wastewater, and identified by 16 S rRNA sequencing. The BS-SMAH-B performance was initially screened using synthetic Mbd solutions under controlled laboratory condition and successively followed by validation in real contaminated soil matrices. The screening experiments showed a high removal efficiency of 97%. However, when applied to real soil samples, the efficiency decreased to 82.05%, reflecting the complexity of the soil matrix. The BS-SMAH-B morphology and composition revealed uniform particles with average pore diameter (12.1 nm). The FT-IR spectral analysis of BS-SMAH-B confirmed numerous active functional groups including –COOH, –OH and –NH2. The elemental composition of C (51.72%), O (27.10%), N (14.97%), was investigated and assessed by the EDX analysis. The zeta potential (–25 mV) of BS-SMAH-B was identified to verify the surface negative sites which are therefore, capable of enhancing the biosorption process of cationic dyes as Mbd. Thermodynamic and kinetic analyses of Mbd biosorption from soil using the BS-SMAH-B revealed that the process is endothermic and taken place spontaneously. The biosorption behavior conformed to the pseudo-second-order, outlining chemisorption as the rate-limiting step. Furthermore, the equilibrium values were well correlated to Langmuir and Freundlich models, with a qmax 10.81 mg/g. To further elucidate the adsorption mechanism and removal efficiency, kinetics models including Elovich, Avrami, Dubinin–Radushkevich (D–R), and Temkin were also applied, providing a more comprehensive understanding of the biosorption characteristics of Mbd. BS-SMAH-B exhibited high performance toward Mbd removal from real Mbd-polluted soil samples via two-step mechanism, involving the initial Mbd biosorption from soil surface by BS-SMAH-B, followed by the biodegradation step in which Mbd molecules were broken down into smaller and harmless products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.